Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4577019 | 0.77 | ALOX15 (0.35) | TSHRSMN1; SMN2ALDH1A1ALOX15HSD17B10 | |
| SCHEMBL2059971 | 0.76 | TSHR (0.42) | TSHRSMN1; SMN2MAPTFAAHALOX15 | |
| SCHEMBL2144008 | 0.74 | TET2 (0.32) | TSHRALOX15HSD17B10 | |
| SCHEMBL1984903 | 0.71 | TSHR (0.34) | TSHRALDH1A1 | |
| SCHEMBL10325251 | 0.70 | THRB (0.37) | TSHRSMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL6241875 | 0.68 | HSD17B10 (0.38) | TSHRSMN1; SMN2ALDH1A1ALOX15HSD17B10 | |
| SCHEMBL8928163 | 0.68 | SMN1; SMN2 (0.41) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL9680823 | 0.68 | TSHR (0.41) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL13506080 | 0.67 | TSHR (0.33) | TSHRALDH1A1 | |
| SCHEMBL1401880 | 0.66 | TET2 (0.43) | ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120238661-A1 | Processes for the Synthesis of Compounds from Cyclic Carbonates | COGNIS IP MANAGEMENT GMBH (DE) | 2012-09-20 | — | — | US | disclosed |
| WO-2012095293-A2 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS FROM CYCLIC CARBONATES | COGNIS IP MANAGEMENT GMBH (DE) | 2012-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238661-A1 | Processes for the Synthesis of Compounds from Cyclic Carbonates | GK, CRYZ, ELOC | TSHR 4538/4885SMN1; SMN2 4852/4885MAPT 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.